Development of a molecular adjuvant to enhance antigen-specific CD8+ T cell responses

Despite promising progress in malaria vaccine development, an efficacious subunit vaccine against P. falciparum remains to be licensed and deployed. This study aimed to improve on the immunogenicity of the leading liver-stage vaccine candidate (ChAd63-MVA ME-TRAP), known to confer protection by elic...

Full description

Bibliographic Details
Main Authors: Halbroth, B, Sebastian, S, Poyntz, H, Bregu, M, Cottingham, M, Hill, A, Spencer, A
Format: Journal article
Published: Springer Nature 2018